Luc Gailhouste
Wako, 3510198, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 18, 2026
miRNA-29b-1-5p mediates an antiviral activity by targeting the HBV entry receptor in human hepatocytes.
Journal: Scientific reports
Published: March 20, 2025
A high-throughput screening platform to identify MYCN expression inhibitors for liver cancer therapy.
Journal: Frontiers in oncology
Published: August 26, 2024
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.
Journal: International journal of cancer
Published: June 17, 2023
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid.
Journal: Cell death & disease
Published: March 24, 2022
Establishment of a Rapid Detection System for ISG20-Dependent SARS-CoV-2 Subreplicon RNA Degradation Induced by Interferon-α.
Journal: International journal of molecular sciences
Published: September 25, 2021
Epigenetic reprogramming promotes the antiviral action of IFNα in HBV-infected cells.
Journal: Cell death discovery
Published: March 30, 2021
Non-Genomic Control of Dynamic MYCN Gene Expression in Liver Cancer.
Journal: Frontiers in oncology
Published: October 17, 2020
MicroRNA-124a inhibits endoderm lineage commitment by targeting Sox17 and Gata6 in mouse embryonic stem cells.
Journal: Stem cells (Dayton, Ohio)
Published: June 21, 2019
MiR-1285-5p/TMEM194A axis affects cell proliferation in breast cancer.
Journal: Cancer science
Published: March 12, 2019
Last Updated: 09/26/2026